510(k) Report

510(k) · Cleared

Cleared

Provant Therapy System

K131979510(k) TraditionalCleared Dec 13, 2013168-day reviewClass II21 CFR 890.5290

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Regenesis Biomedical, Inc. · ILX Diathermy, Shortwave, For Use Other Than Applying Therapeutic Deep Heat

Cleared on Dec 13, 2013 as substantially equivalent to K091791 (Regenesis Biomedical, Inc., 2010) after a 168-day review. Its family tree reaches back 1 generation to 2010.

Decided
Dec 13, 2013
Review
168 days
Class
Class II
Product code
ILX
Recalls
None
Predicates
1

Its longest line of descent runs back 1 generation to K091791 (2010). No later device cites it as a predicate yet.

K091791 · Provant System, Model 4201 · Regenesis Biomedical, Inc. · 2010201020122014
  1. Root · 1 generation backK091791 Provant System, Model 4201Regenesis Biomedical, Inc. · 2010
  2. This deviceK131979 Provant Therapy SystemRegenesis Biomedical, Inc. · 2013
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K091791Provant System, Model 4201Regenesis Biomedical, Inc.2010—
0 (this device)K131979Provant Therapy SystemRegenesis Biomedical, Inc.2013—
FIG. 1 — Lineage of K131979, 2010–2013Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in ILX? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new ILX device

  1. #1 K241395 Active System; Avenue8score 9.4 · 4 generations · no Class I recall
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K091791Provant System, Model 4201
Summary page 5
…Provant Therapy System Common Name Nonthermal shortwave diathermy device Device Classification Class 11l Product Code ILX - Predicate Provant System, Model 4201 (K091791)” Device(s) ’ Performance - | Performance standards have not been established by the FDA under section Standards 514 of the Fed…
Regenesis Biomedical, Inc.2010—

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Its one ancestor has no recall.

How does its category compare?

All ILX devices

ILX Diathermy, Shortwave, For Use Other Than Applying Therapeutic Deep Heat: FDA decisions, review times, recalls and adverse event reports over 20 years. 2013, this device’s year, is highlighted.

FDA decisions per year · ILX

1in 2024

2007: 12008: 12009: 22010: 12012: 12013: 22019: 12020: 12024: 1
2007high 2 (2009) · low 0 (2011)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · ILX

Too few ILX 510(k)s in any year since 2007 to give a median.

Recalls per year · ILX

1in 2008

2008: 1
2007high 1 (2008) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · ILX

1in 2025

2007: 12008: 22009: 12011: 12016: 12023: 12025: 1
2007high 2 (2008) · low 0 (2010)2025

MAUDE reports naming product code ILX, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071—01
20081—12
20092—01
20101—00
20110—01
20121—00
20132—00
20140—00
20150—00
20160—01
20170—00
20180—00
20191—00
20201—00
20210—00
20220—00
20230—01
20241—00
20250—01
20260—0—

What is it indicated for?

The Provant Therapy System is indicated for adjunctive use in the palliative

treatment of postoperative pain and edema in superficial soft tissue.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K131979: Provant Therapy System.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K131979

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026